Overweight Clinical Trial
— PAC-MAnOOfficial title:
The Effect of a Physical Activity Consultation in the Management of Adolescent Overweight, Including Anthropometry, Physical Activity Levels, Cardiorespiratory Fitness, and Endothelial Health
Verified date | April 2019 |
Source | University of Lisbon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The prevalence of pediatric obesity makes this condition a worldwide public health concern.
Physical Activity (PA) is recognized as having many health benefits, many of them related to
obesity and its comorbidities. Despite of all the efforts, the majority of the overweight
children/adolescents still present low levels of PA and high levels of sedentary behaviors.
Thus, it seems that the greatest challenge is to influence behavior change in order to
increase PA exposure in this population. PA consultation can be a cost-effective way of
enhancing PA and improve weight status among overweight children.
The main objective of this study is to analyze if the inclusion of a PA consultation in a
multidisciplinary program for the management of adolescent overweight improves body mass
index (BMI) z-score, PA levels and sedentary behavior outcomes at six and twelve months,
compared to those attending only the Pediatric and the Dietetic consultations.
This study was designed as a non-randomized, controlled clinical trial with six months
duration and follow-up at the 12th month, that will include overweight adolescents (BMI ≥
p85) aged 12 to 17, attending the Clinic for the first time, and accepted to be enrolled.
Those with (i) major pathologies (other than obesity or its related comorbidities), (ii)
inability to perform regular PA, (iii) mental disorders, (iv) smoking habits, (v) under any
kind of prescription (other than antihypertensives or metformin), or (vi) being involved in
another weight loss program will be excluded. According to the sample size calculation, we
expect to recruit 129 participants that will be allocated in three groups by consecutive
sampling: (i) control group - standard care (Pediatric and Dietitian consultations); (ii)
intervention group I - standard care plus PA consultation; (iii) intervention group II - 2
weekly exercise sessions additionally to the standard care and PA consultations..
Status | Active, not recruiting |
Enrollment | 165 |
Est. completion date | December 2019 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Coming from the Lisbon region; - A BMI = p85 for gender and age; - Attending the Clinic for the first time; - Accepted to be enrolled. Exclusion Criteria: - Major pathologies (other than obesity or its related comorbidities); - Inability to perform regular PA; - Mental disorders; - Smoking habits; - Under any kind of prescription (other than antihypertensives or metformin); - Being involved in another weight loss program. |
Country | Name | City | State |
---|---|---|---|
Portugal | Hospital de Santa Maria | Lisbon |
Lead Sponsor | Collaborator |
---|---|
University of Lisbon |
Portugal,
Flattum C, Friend S, Story M, Neumark-Sztainer D. Evaluation of an individualized counseling approach as part of a multicomponent school-based program to prevent weight-related problems among adolescent girls. J Am Diet Assoc. 2011 Aug;111(8):1218-23. doi: 10.1016/j.jada.2011.05.008. — View Citation
Henderson M, Daneman D, Huot C, McGrath J, Lambert M, Hux J, Booth GL, Hanley A. The impact of exercise consultation on activity levels and metabolic markers in obese adolescents: a pilot study. Int J Pediatr Endocrinol. 2010;2010:681510. doi: 10.1155/2010/681510. Epub 2010 Sep 26. — View Citation
Kelishadi R, Malekahmadi M, Hashemipour M, Soghrati M, Soghrati M, Mirmoghtadaee P, Ghatrehsamani S, Poursafa P, Khavarian N. Can a trial of motivational lifestyle counseling be effective for controlling childhood obesity and the associated cardiometabolic risk factors? Pediatr Neonatol. 2012 Apr;53(2):90-7. doi: 10.1016/j.pedneo.2012.01.005. Epub 2012 Mar 3. — View Citation
McCallum Z, Wake M, Gerner B, Baur LA, Gibbons K, Gold L, Gunn J, Harris C, Naughton G, Riess C, Sanci L, Sheehan J, Ukoumunne OC, Waters E. Outcome data from the LEAP (Live, Eat and Play) trial: a randomized controlled trial of a primary care intervention for childhood overweight/mild obesity. Int J Obes (Lond). 2007 Apr;31(4):630-6. Epub 2006 Dec 12. — View Citation
Walpole B, Dettmer E, Morrongiello BA, McCrindle BW, Hamilton J. Motivational interviewing to enhance self-efficacy and promote weight loss in overweight and obese adolescents: a randomized controlled trial. J Pediatr Psychol. 2013 Oct;38(9):944-53. doi: 10.1093/jpepsy/jst023. Epub 2013 May 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body mass index (BMI) z-score | 12 months | ||
Primary | Physical activity (PA) levels | 12 months | ||
Primary | Sedentary behavior | Questionnaire ASAQ (Adolescent Sedentary Activity Questionnaire) | 12 months | |
Secondary | Cardiorespiratory fitness (CRF) | Maximal (Cycle ergometer and gas analyser) and submaximal (step) testes | 12 months | |
Secondary | Carotid intima-media thickness (cIMT) | 12 months | ||
Secondary | Pulse wave velocity (PWV) | 12 months | ||
Secondary | Body composition | 12 months | ||
Secondary | Lipid profile (TC, LDL-C, HDL-C) | 12 months | ||
Secondary | Glucose metabolism (Glucose, Insulin, HOMA-IR) | 12 months | ||
Secondary | inflammation (C-RP) | 12 months | ||
Secondary | Cost-effectiveness (CE) | CE will be estimated for the standard intervention, and for both the intervention groups. CE ratio = C/E, (where C = cost of each intervention [human and material resources in €]; and E = effectiveness of each intervention [BMI z-score outcome]. The lowest CE ratio will represent the most cost-effective intervention. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A | |
Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |